Mike’s wife Jeanie was diagnosed with Multiple Myeloma in June, 2010. In an effort to motivate Jeanie through recovery of her first stem cell transplant in 2010, Mike signed up for his first sprint triathlon with her in 2011 and has been pursuing greater challenges every year. He has cheered her on through 3 marathons post-transplant, including Boston and NYC for the MMRF, and has joined her for a marathon and a couple of Spartan events, a Spartan Beast in 2014 and Spartan Fenway as part of the MMRF Endurance Team in 2015. As a frequent member of MMRF Endurance Team events, Mike has participated in several MMRF events including the inaugural R2V as a member of the Desert Team ( CA to AZ ) and his first ironman at Mont-Tremblant. He has personally seen the positive impact that these events have made on the patients and the MM community, along with the incredible results and quality of life that the MMRF has delivered because of the fundraising.
At Janssen Oncology, we’re shaping the future of cancer treatment. In the process, we’re striving to change expectations of what a cancer diagnosis means. Our purpose is driven by an urgency and commitment to bringing transformational cancer solutions to the people who need them. Passionate about our work, we are driven by the personal connection many of us share with the disease. With our partners, we focus on delivering solutions that make a positive impact on human health. We are part of Janssen Biotech, Inc., and the Janssen Pharmaceutical Companies of Johnson & Johnson.
About Janssen OncologyClick below to learn more about a treatment option for multiple myeloma. If you’re also interested in getting more information from Janssen, sign up for ongoing communications.
Learn More
